Replacement | Medicines | 03/07/2014

The marketing authorization holder informed its supplied customers by letter dated July 1, 2014, that the sedacoron batch DV6862 delivered in the period from February 2014 to May 2014 exhibited increased crystallization, so that a precautionary replacement will be carried out.

Name of the medicinal product Sedacoron 150 mg - Konzentrat zur Infusionsbereitung
Marketing authorisation number(s) 1-18027
Marketing authorisation holder Ebewe Pharma GmbH Nfg KG
Batch number(s) DV6862
Classification of the recall2
BASG reference number INS - 640.001 - 1 092

Further inquiry note